- Home
- PPTA vs TERN Comparison
PPTA vs TERN Comparison
Compare PPTA & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPTA
- TERN
- Stock Information
- Founded
- PPTA 2011
- TERN 2017
- Country
- PPTA United States
- TERN United States
- Employees
- PPTA N/A
- TERN N/A
- Industry
- PPTA Precious Metals
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- PPTA Basic Materials
- TERN Health Care
- Exchange
- PPTA Nasdaq
- TERN Nasdaq
- Market Cap
- PPTA 573.6M
- TERN 586.0M
- IPO Year
- PPTA N/A
- TERN 2021
- Fundamental
- Price
- PPTA $10.60
- TERN $6.17
- Analyst Decision
- PPTA Strong Buy
- TERN Buy
- Analyst Count
- PPTA 2
- TERN 6
- Target Price
- PPTA $18.50
- TERN $16.42
- AVG Volume (30 Days)
- PPTA 369.3K
- TERN 1.3M
- Earning Date
- PPTA 11-13-2024
- TERN 11-12-2024
- Dividend Yield
- PPTA N/A
- TERN N/A
- EPS Growth
- PPTA N/A
- TERN N/A
- EPS
- PPTA N/A
- TERN N/A
- Revenue
- PPTA N/A
- TERN N/A
- Revenue This Year
- PPTA N/A
- TERN N/A
- Revenue Next Year
- PPTA N/A
- TERN N/A
- P/E Ratio
- PPTA N/A
- TERN N/A
- Revenue Growth
- PPTA N/A
- TERN N/A
- 52 Week Low
- PPTA $2.69
- TERN $3.59
- 52 Week High
- PPTA $10.75
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- PPTA 59.98
- TERN 31.82
- Support Level
- PPTA $8.67
- TERN $6.99
- Resistance Level
- PPTA $9.64
- TERN $7.53
- Average True Range (ATR)
- PPTA 0.69
- TERN 0.47
- MACD
- PPTA -0.06
- TERN -0.02
- Stochastic Oscillator
- PPTA 93.02
- TERN 16.57
About PPTA Perpetua Resources Corp.
Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.